Study to Evaluate and Compare the Bioequivalence of Two Abaloparatide-sMTS Treatments in Healthy Women.

Inclusion Criteria: * Female subjects aged 40 to 65 years old, inclusive, at Screening * Good general health as determined by medical history and physical exam (including vital signs, and has a body mass index between 18 and 34 kg/m\^2 inclusive) * Laboratory tests within the normal range * Serum 25-hydroxyvitamin D values must be \> 20 ng/mL Exclusion Criteria: * Presence or history of any disorder that may prevent the successful completion of the study. * Diagnosed with osteoporosis, Paget's disease, or other metabolic bone diseases (eg, vitamin D deficiency or osteomalacia), or had a non-traumatic fracture within 1 year prior to the initial screening; * History of any cancer within the past 5 years other than squamous or basal cell carcinoma; * History of allergy to abaloparatide or drugs in a similar pharmacological class;